Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The sympathetic nervous system: the muse of primary hypertension

Journal of Human Hypertension volume 16, pages S64–S69 (2002)Cite this article

Abstract

Von Euler characterised the sympathetic neurotransmitter noradrenaline (NA) and postulated that excessive neural tone was a cause of primary hypertension (PH). Thirty years ago, we found raised NA levels in 30–40% of young patients with PH. Laragh found plasma renin activity (PRA) a risk marker for coronary artery disease. With Esler, Miura, and Campese, a close association was found of plasma NA with PRA. We found raised tyrosine hydroxylase activity (AC) in the hearts of a rabbit model of sinoaortic denervated hypertension and in PH with raised plasma NA. Esler utilised titrated NA infusion and described increased spillover of NA from heart, kidney and subcortical areas of brain of patients with PH. With Eide we found raised cerebrospinal fluid (CSF) NA in PH (not secondary hypertension) and with Kolloch and Miura, we found raised plasma/CSF NA in conjunction with reduced dopaminergic tone. With Shkvatsabaya, Yurenev and Davison, we found that relaxation therapy improved the anger ambience and blood pressure of PH with raised plasma NA vs those with normal NA levels. Campese found a hypothalamic source of raised blood pressure in two rat models – microphenol treated and ischaemic kidney. The resulting hypertension was associated with raised NA turnover of their hypothalamic centres. Finally, with Hsueh and Hodis, we found raised plasma NA in association with insulin resistance increased left ventricular mass and intimal medial hypertrophy in Mexican-American diabetics and their yet unaffected offspring. Reliable estimates of human sympathetic AC, including levels of plasma NA in the effluent of selected organs and peripheral venous and arterial sites, may eventually be displaced by techniques using genetic analysis and molecular biology. Never the less, the sympathetic nervous system appears to play an important role in the pathogenesis, sequelae and therapy of PH.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Campese V . Personal communication. Manuscript in preparation

  2. Goldstein D et al. Cardiac sympathetic denervation in Parkinson disease Ann Int Med 2000 133: 338–347

    Article  CAS  Google Scholar 

  3. Esler M et al. Am J Cardiol 1997 80: 76

  4. Robertson D . Dissociation between neural and vascular responses to sympathetic stimulation Hypertension 2000 35: 76–81

    Article  Google Scholar 

  5. DeQuattro V, Chan S . Raised plasma catecholamines in somepatients with primary hypertension Lancet 1972 1: 806–809

    Article  CAS  Google Scholar 

  6. Engelman K, Portnoy B, Sjoerdsma A . Catecholamine-cylic-AMP-angiotensin receptors. Plasma catecholamine concern in patients with hypertension Circ Res (Suppl 1) 141–146

  7. Goldstein D . Plasma norepinephrine in essential hypertension: a study of the studies Hypertension 1981 3: 48

    Article  CAS  Google Scholar 

  8. DeQuattro V, Miura Y . Neurogenic factors in hypertension: mechanism or myth? Am J Med 1973 55: 362–378

    Article  CAS  Google Scholar 

  9. Alderman MH et al. N Engl J Med 1991 324: 1098

  10. Esler M et al. Mild high-renin essential hypertension: a neurogenic human hypertension? N Engl J Med 1977 296: 405–511

    Article  CAS  Google Scholar 

  11. DeQuattro V, Campese V, Miura Y, Meijer D . Increased plasma catecholamines in high renin hypertension Am J Cardiol 1976 38: 801–804

    Article  CAS  Google Scholar 

  12. DeQuattro V, Nagatsu T, Maronde R, Alexander N . Catecholamine synthesis in rabbits with neurogenic hypertension Circ Res 1969 24: 545–555

    Article  CAS  Google Scholar 

  13. DeQuattro V et al. Increased plasma catechlamines and vas deferans norepinephrine biosynthesis in men with elevated blood pressure Circ Res 1975 36: 118–126

    Article  CAS  Google Scholar 

  14. Eide I et al. Raised cerebrospinal fluid noradrenaline in somepatients with primary hypertension Hypertension 1979 1: 255–260

    Article  CAS  Google Scholar 

  15. DeQuattro V et al. Central and regional normetanephrine in evaluation of neurogenic aspects of hypertension: aid to diagnosis of pheochromocytoma Clin Sci 1980 59: 275S–277S

    Article  CAS  Google Scholar 

  16. DeQuattro V et al. Central and peripheral noradrenergic mechanisms in primary hypertension Fed Proceed 1984 43: 47–51

    CAS  Google Scholar 

  17. Kolloch R, Kobayashi K, DeQuattro V . Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension Hypertension 1980 2: 390–394

    Article  CAS  Google Scholar 

  18. Ferrier C et al. J Hypertens 1993 11: 1217

  19. DeQuattro V et al. Left ventricular hypertrophy and neural tone in hypertension: divergent effects of diuretic and relaxation therapy. Hypertension: neural tone and the heart In: Hegyeli R (ed) Proceedings of the Fourth Joint US-USSR Symposium on Arterial Hypertension, NHLBI, 1985 US Department of Health & Human Service NIH Pub. #86–2704, January 1986

    Google Scholar 

  20. Lee DP et al. Neurohumoral mechanisms and left ventricular hypertrophy in primary hypertension. Effects of hygienic therapy J Hum Hypertens 1987 1: 147–151

    CAS  PubMed  Google Scholar 

  21. Hagaa D et al. Mode-specific impact of relaxation training for hypertensive men with type A behavior pattern Behav Ther 1994 25: 209–223

    Article  Google Scholar 

  22. Atakhanov C, Kim D, DeQuattro V . Noradrenergic excess in primary hypertensives with reduced oxidative deamination: a syndrome mimicking pheochromocytoma Am J Hypertens 1995 8: 125A

    Article  Google Scholar 

  23. Horwitz D, Sjoerdsma A . Hypertension 1964 8: 39–48

  24. Lee DP, Kimura S, DeQuattro V . Noradrenergic activity and silent ischaemia in hypertensives with stable angina: effect of metoprolol Lancet 1989 1: 403–406

    CAS  PubMed  Google Scholar 

  25. Lee DP, Rigonan K, DeQuattro V . Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of of immediate release nifedipine JACC 1993 22: 1438–1445

    Article  CAS  Google Scholar 

  26. Iosa D et al. Plasma norepinephrine in Chagas’ cardioneuropathy: a marker of progressive dysautonomia Am Heart J 1989 117: 882–886

    Article  CAS  Google Scholar 

  27. Tecumeseh Julius . Am J Hypertens 1993 6: 891

  28. Julius S . Clin Exp Hypertens 1996 18: 305–321

  29. DeQuattro V et al. Labetalol blunts morning pressor surge in systolilc hypertension Hypertension 1988 11 (Suppl 1): I-198–I-201

    Google Scholar 

  30. Li DP et al. Neurogenic factors and insulin resistance participate in the genesis and sequelae of the hypertension in Mexican Americans J Hypertens 1998 16 (Suppl 2): S176

    Google Scholar 

  31. Folkow B . Acta Physiol Scand 1984 (Suppl S27): 9

Download references

Author information

Author notes

  1. M Feng: M Feng, MD, Visiting Scholar, People's Republic of China

Authors and Affiliations

  1. Keck School of Medicine, University of Southern California, Los Angeles, California, USA

    V DeQuattro & M Feng

Authors
  1. V DeQuattro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeQuattro, V., Feng, M. The sympathetic nervous system: the muse of primary hypertension. J Hum Hypertens 16 (Suppl 1), S64–S69 (2002). https://doi.org/10.1038/sj.jhh.1001346

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001346

Keywords

This article is cited by

Search

Advanced search

Quick links